Survival comparison of patients with lung and pleural metastases undergoing diagnostic and therapeutic surgery
initial experience of a thoracic surgery service
DOI:
https://doi.org/10.23925/1984-4840.2021v23i2a4Keywords:
Survival Analysis, Lung Neoplasms, Neoplasm Metastasis, Thoracotomy, Thoracic SurgeryAbstract
Objective: To analyze and compare the survival of patients with pulmonary and pleural metastases in an initial thoracic surgery service. Methods: Retrospective longitudinal study of 19 patients with pulmonary and pleural metastases who underwent surgery between 2016 and 2020. Survival was analyzed using the Kaplan Meier curve. Results: Most were female, 84.2%, with a mean age of 64 years and 68.4% were non-smokers. Comorbidities were detected in 73.7% of patients, with arterial hypertension being the most prevalent. The most common primary tumors were breast and lung cancer. The most frequent approach (52.7%) was through videothoracoscopy. Chemotherapy treatment covered 84.2% of patients. Of the six patients who developed postoperative complications during hospitalization, 33.3% had pneumonia and 1 died. Overall survival at 30 months was 57.9%. Patients with pulmonary metastasis showed longer 30-month survival compared to those with pleural metastasis (75% vs. 50%; p=0.017). Regarding the primary tumor, patients with breast carcinoma had a 12-month survival of 85%, while among patients with colorectal cancer, the survival was 50%. Conclusion: According to our study, patients with pleural metastases have a worse prognosis when compared to patients with pulmonary metastases. The primary location of the tumor is associated with patient survival.
Downloads
Metrics
References
- Cheung F, Alam N, Wright G. Pulmonary metastasectomy: analysis of survival and prognostic factors in 243 patients. ANZ J Surg. 2018;88(12):1316-21. doi: 10.1111/ans.14811.
- Silva Júnior CT, Marchi E, Teixeira LR. Diagnóstico e tratamento dos derrames pleurais malignos. Pulmão RJ. 2016;25(1):17-20.
- Schirren J, Schirren M, Lampl L, Sponholz S. Surgery for pulmonary metastases: quo vadis? Eur J Cardiothorac Surg. 2017;51(3):408-10. doi: 10.1093/ejcts/ezw441.
- Poletti GB, Toro IFC, Alves TF, Miranda EC, Seabra JC, Mussi RK. Descriptive analysis of and overall survival after surgical treatment of lung metastases. J Bras Pneumol. 2013;39(6):650-8. doi: 10.1590/S1806-37132013000600003
- Santos GT, Prolla JC, Camillo ND, Zavalhia S, Ranzi AD, Bica CG. Fatores clínicos e anatomopatológicos que influenciam a sobrevida de pacientes com câncer de mama e derrame pleural neoplásico. J Bras Pneumol. 2012;38(4):487-93. doi: 10.1590/S1806-37132012000400011
- Hochman B, Nahas FX, Oliveira Filho RS, Ferreira LM. Desenhos de pesquisa. Acta Cir Bras. 2005;20 Suppl 2:2-9. doi: 10.1590/S0102-86502005000800002
- Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T, et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg. 2004;78(1):238-44. doi: 10.1016/j.athoracsur.2004.02.017.
- Sakamoto T, Tsubota N, Iwanaga K, Yuki T, Matsuoka H, Yoshimura M. Pulmonary resection for metastasis from colorectal cancer. Chest. 2001;119(4):1069-72. doi:10.1378/chest.119.4.1069
- Younes RN, Haddad F, Ferreira F, Gross JL. Ressecção cirúrgica de metástases pulmonares: estudo prospectivo em 182 pacientes. Rev Ass Méd Brasil. 1998;44(3):218-25.
- Skok K, Hladnik G, Grm A, Crnjac A. Malignant pleural effusion and its current management: a review. Medicina (Kaunas). 2019;55(8):490. doi: 10.3390/medicina55080490.
- Ried M, Hofmann HS. The treatment of pleural carcinosis with malignant pleural effusion. Dtsch Arztebl Int. 2013;110(18):313-8. doi: 10.3238/arztebl.2013.0313.
- Rena O, Casadio C, Viano F, Cristofori R, Ruffini E, Filosso PL, et al. Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience. Eur J Cardio-Thor Surg. 2002;21(5):906–12. doi: 10.1016/S1010-7940(02)00088-X.
- Kanzaki R, Okami J, Takami K, Iwasaki T, Ikeda N, Funakoshi Y, et al. Outcomes of surgical resection for pulmonary metastasis from ovarian cancer. J Cardiothorac Surg. 2020;15(1):182. doi: 10.1186/s13019-020-01231-x.
- Cormio G, Rossi C, Cazzolla A, Resta L, Loverro G, Greco P, et al. Distant metastases in ovarian carcinoma. Int J Gynecol Cancer. 2003;13(2):125-129. doi:10.1046/j.1525-1438.2003.13054.x.
- Otsuka I, Ono I, Akamatsu H, Sunamori M, Aso T. Pulmonary metastasis from endometrial carcinoma. Int J Gynecol Cancer. 2002;12(2):208-13. doi: 10.1046/j.1525-1438.2002.01095.x.
- Barbetakis N, Antoniadis T, Kaplanis K, Deligiannis D, Toliou T, Tsilikas Ch. Metastatic squamous cell vulvar carcinoma of the lung: a case report and review of the literature. Eur J Gynaecol Oncol. 2002;23(5):475-6.
- Kim W, Park IK, Park S, Kang CH, Kim YT. Clinical course of non-small cell lung cancer patients with dry pleural dissemination Retrospective observational study. Medicine (Baltimore). 2020;99(11):19533. doi: 10.1097/MD.0000000000019533.
- Okamoto T, Iwata T, Mizobuchi T, Hoshino H, Moriya Y, Yoshida S, et al. Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy. Eur J Cardio-Thoracic Surg. 2012;41(1):25-30. doi: 10.1016/j.ejcts.2011.04.010.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista da Faculdade de Ciências Médicas de Sorocaba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Os autores no momento da submissão transferem os direitos autorais, assim, os manuscritos publicados passam a ser propriedade da revista.
O conteúdo do periódico está licenciado sob uma Licença Creative Commons 4.0, esta licença permite o livre acesso imediato ao trabalho e que qualquer usuário leia, baixe, copie, distribua, imprima, pesquise ou vincule aos textos completos dos artigos, rastreando-os para indexação, passá-los como dados para o software, ou usá-los para qualquer outra finalidade legal.